PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24490062-4	2013	Relative mRNA expression of TLR3/RIG-I signaling genes involved in IFN- beta production was correlated with positive- and negative-strand HCV RNAs in pretreatment liver tissues responsive and nonresponsive to peginterferon and ribavirin for chronic hepatitis C genotype 1.	Ribavirin	227-236	toll like receptor 3	Homo sapiens	28-32	
25766991-2	2015	OBJECTIVES: To analyze the association between Toll-like receptor-3 (TLR3) polymorphisms (rs3775291 and rs13126816) and virologic response to pegylated interferon-alpha plus ribavirin (pegIFNalpha/RBV) therapy in HIV/HCV coinfected patients.	Ribavirin	174-183	toll like receptor 3	Homo sapiens	47-67	
25766991-2	2015	OBJECTIVES: To analyze the association between Toll-like receptor-3 (TLR3) polymorphisms (rs3775291 and rs13126816) and virologic response to pegylated interferon-alpha plus ribavirin (pegIFNalpha/RBV) therapy in HIV/HCV coinfected patients.	Ribavirin	174-183	toll like receptor 3	Homo sapiens	69-73	
25766991-2	2015	OBJECTIVES: To analyze the association between Toll-like receptor-3 (TLR3) polymorphisms (rs3775291 and rs13126816) and virologic response to pegylated interferon-alpha plus ribavirin (pegIFNalpha/RBV) therapy in HIV/HCV coinfected patients.	Ribavirin	197-200	toll like receptor 3	Homo sapiens	47-67	
25766991-2	2015	OBJECTIVES: To analyze the association between Toll-like receptor-3 (TLR3) polymorphisms (rs3775291 and rs13126816) and virologic response to pegylated interferon-alpha plus ribavirin (pegIFNalpha/RBV) therapy in HIV/HCV coinfected patients.	Ribavirin	197-200	toll like receptor 3	Homo sapiens	69-73	
23967741-10	2013	During the course of peg-IFNalpha-2a plus RBV combination therapy, the expression ratios of PD-1 and TLR4 on PBMCs showed a decreasing trend, while TLR3 expression showed an increasing trend.	Ribavirin	42-45	toll like receptor 3	Homo sapiens	148-152	
23967741-13	2013	Peg-IFNalpha-2a plus RBV treatment-induced suppression of HCV replication results in a significant reduction in PD-1 and TLR4 expression on the surface of PBMCs, but a remarkably elevated level of TLR3 expression.	Ribavirin	21-24	toll like receptor 3	Homo sapiens	197-201	
22023039-1	2011	PURPOSE: This work was carried out to study the level of pretreatment hepatic expression of Toll like receptor 3 (TLR3) among chronic HCV patients, aiming to determine if there are consistent differences in gene expression, between those who show complete early virological response (cEVR) at week-12 of Pegylated-Interferon alpha-2a plus ribavirin treatment and others who are not responding to this combination, also if this could be used to predict treatment outcomes.	Ribavirin	339-348	toll like receptor 3	Homo sapiens	114-118	
19674283-10	2010	Low hepatic TLR3 expression is a novel predictor of response to peginterferon plus ribavirin in genotype 1 patients.	Ribavirin	83-92	toll like receptor 3	Homo sapiens	12-16